STOCK TITAN

Absci (ABSI) innovation chief buys 100K shares at $2.29 each

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Absci Corp’s Chief Innovation Officer buys additional shares. Executive Andreas Busch reported an open-market purchase of 100,000 shares of Absci common stock at a price of $2.29 per share on March 12, 2026, in accordance with the company’s trading policies. This increased his direct ownership to 421,446 shares.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Busch Andreas

(Last) (First) (Middle)
C/O ABSCI CORPORATION
18105 SE MILL PLAIN BLVD

(Street)
VANCOUVER WA 98683

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Absci Corp [ ABSI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Innovation Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/12/2026 P 100,000(1) A(1) $2.29 421,446 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Open market purchase of shares in accordance with Issuer's trading policies.
Remarks:
/s/ Shelby Walker, attorney-in-fact 03/16/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Absci (ABSI) report for Andreas Busch?

Absci reported that Chief Innovation Officer Andreas Busch bought 100,000 common shares. The open-market purchase occurred on March 12, 2026, at $2.29 per share, increasing his direct holdings to 421,446 shares according to the Form 4 filing.

At what price did Absci’s Chief Innovation Officer buy shares on March 12, 2026?

He bought Absci common stock at $2.29 per share. The Form 4 shows an open-market purchase of 100,000 shares at this price, completed under the company’s trading policies, and raising his directly held position to 421,446 shares after the transaction.

How many Absci shares does Andreas Busch hold after his latest Form 4 transaction?

After the reported purchase, Andreas Busch directly owns 421,446 Absci common shares. The Form 4 shows he acquired 100,000 shares in an open-market trade at $2.29 per share, and lists this total as his direct holdings following the transaction.

Was the Absci (ABSI) insider share purchase an open-market transaction?

Yes, the transaction was an open-market purchase of Absci common stock. The Form 4 describes the code as a purchase and the footnote specifies it was completed in the open market under the issuer’s trading policies at a price of $2.29 per share.

What role does the insider in Absci’s latest Form 4 filing hold?

The insider in the latest Form 4 filing, Andreas Busch, serves as Absci’s Chief Innovation Officer. He is reported as an officer, not a director or 10% owner, and the filing details his open-market purchase of 100,000 common shares at $2.29 per share.
Absci Corp

NASDAQ:ABSI

View ABSI Stock Overview

ABSI Rankings

ABSI Latest News

ABSI Latest SEC Filings

ABSI Stock Data

463.14M
129.72M
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
VANCOUVER